HIBCH and hepatocellular carcinoma: While there is a lack of research on the molecular characteristics of HIBCH (3-hydroxyisobutyryl-CoA hydrolase) in HCC, high expression of HIBCH has been linked to poor survival in colorectal cancer patients, as well as increased cell growth, resistance to apoptosis, and reduced autophagy in colorectal cancer cells.